Closed · CDC-RFA-DP21-2102 · CFDA 93.810 · Discretionary
Paul Coverdell National Acute Stroke Program
Federal grant opportunity posted by Centers for Disease Control - NCCDPHP, cataloged on Grants.gov.
- $500K-$650K
- Award range
- Closed
- Status
- March 18, 2021
- Close date
- 13
- Expected awards
The verdict
Paul Coverdell National Acute Stroke Program is a closed discretionary listing from Centers for Disease Control - NCCDPHP that offered $500,000 -- $650,000 across 13 expected awards. Future funding cycles may be published under the same CFDA number.
- $500K-$650K
- award range
- Closed
- application status
- 13
- expected awards
- 93.810
- CFDA program
Opportunity snapshot. This Grants.gov announcement - Paul Coverdell National Acute Stroke Program - is cataloged under number CDC-RFA-DP21-2102 and tied to CFDA assistance listing 93.810, posted by Centers for Disease Control - NCCDPHP. Grants.gov currently shows the opportunity as closed, first posted on January 5, 2021. The funding category is Discretionary, delivered as a cooperative agreement.
Award economics. The award range on file is $500,000 -- $650,000. The agency has projected $23.1 million in total estimated funding for this announcement. It expects to issue 13 awards. If the agency funds the expected 13 awards from the $23.1 million estimated pool, the average award works out to roughly $1.8 million. Cost sharing is not required, so applicants do not need to commit matching funds to be competitive on this opportunity. Federal award ranges are often upper bounds; actual allocations reflect program appropriations, the strength of the applicant pool, and the evaluation committee's scoring.
Deadline and action path. This opportunity closed on March 18, 2021. Future funding cycles may be published under the same CFDA number, so monitoring the parent program page is the most reliable way to catch re-announcements. Every Grants.gov submission requires an active SAM.gov registration and a Unique Entity ID. Review the Eligibility section below carefully, federal eligibility categories (nonprofit, state or local government, tribal, individual, educational institution, small business) have distinct registration and reporting requirements. Pre-application outreach to the listed agency contact is permitted and often welcomed, it helps clarify scope and scoring priorities. Before acting on the deadline or award figures above, verify them directly on the official Grants.gov listing, amendments can change dates and amounts after this page was last refreshed.
Award Range
$500,000 -- $650,000
Close Date
March 18, 2021
Electronically submitted applications must be submitted no later than 11:59 p.m., ET, on the listed application due date.
Posted
January 5, 2021
Est. Total Funding
$23,100,000
Expected Awards
13
Instrument
Cooperative Agreement
Description
Heart disease is the leading cause of death in the United States. Cardiovascular Disease (CVD), including heart disease, stroke, and other vascular diseases, accounts for >800,000, or about 1 in 3, deaths/year, and around 1 in 5 who die from CVD are younger than 65 years. CVD is costly, with an estimated 15%, or 1 in 7 health care dollars spent on CVD. Stroke is the 5th leading cause of death and is a major cause of disability. After decades of decline, progress has slowed in preventing stroke deaths. About 795,000 people have a stroke each year. Someone in the United States has a stroke every 40 seconds and every 4 minutes, someone dies of stroke. About 610,000 of these are first or new stroke events and about 185,000 strokes—nearly 1 of 4—are in people who have had a previous stroke. Stroke costs the United States an estimated $34 billion each year, with this figure representing the cost of health care services, medicines to treat stroke, and missed days of work. The risk of having a stroke varies with race and ethnicity, but it is clear the risk of having a first stroke is nearly twice as high for Black individuals as their White counterparts, and Black persons have the highest rate of death due to stroke among all races/ethnicities. Stroke death rates among Hispanic individuals increased by 6% each year from 2013 to 2015. Stroke deaths also increased in southern states, where high burden populations, specifically communities of color, exist. High blood pressure (hypertension) is the single most important treatable risk factor for stroke and less than half of those with hypertension are controlled. High blood pressure is more common in non-Hispanic Black adults (54%) than in non-Hispanic White adults (46%), non-Hispanic Asian adults (39%), or Hispanic adults (36%). High blood cholesterol, smoking, obesity, and diabetes also significantly contribute to stroke risk and have a huge impact on high burden populations. These data are disturbing because about 80% of strokes are preventable. These data also highlight the critical need to improve access to and quality of care for those at highest risk for stroke events and stroke patients along the continuum of care, particularly among high burden populations. People of color experience disparities in access to health care, the quality of care received, and health outcomes. Analyses of data collected under previous cycles of this cooperative agreement found that women and African Americans were less likely to be treated with alteplase within 60 minutes. Other analyses determined that ischemic stroke patients who were women and Medicaid or Medicare recipients had lower odds of receiving defect-free care. A robust body of research supports the assertion that biases, both unconscious and implicit by clinical providers, can significantly impact health care delivery, clinical decision-making, patient-provider interactions, treatment decisions, treatment adherence, and the resulting patient health outcomes. This NOFO will build upon accomplishments, outcomes achieved, and lessons learned through CDC-RFA-DP15-1514 by focusing efforts on implementing a state-wide registry, along with evidence-based strategies to measure, track, and improve access to and quality of care for those individuals at highest risk for stroke events and for stroke patients from onset of stroke symptoms through rehabilitation and recovery. These efforts must accurately identify disparities and then effectively address the relevant inequities including identification, assessment, and treatment across the continuum of care for those at highest risk for stroke events and for stroke patients.
Eligibility
Grants.gov lists this opportunity under eligibility category codes 00, 01, 02, 04, 05, 06, 07, 08, 11, 12, 13, 20, 22, 23, 99. These codes correspond to applicant types (state/local government, tribal organization, nonprofit, educational institution, individual, small business, etc.) defined in Grants.gov's own eligibility reference. See the current Grants.gov eligibility categories or check the official listing below for this opportunity's exact eligibility statement.
Official Listing on Grants.gov
View full details, application forms, and submission instructions.
Agency Contact
Rebekah Buckley Coverdell2102Comms@cdc.gov
Key Dates
Frequently Asked Questions
What is this grant opportunity?
Is this opportunity still open?
How much funding is available?
How do I apply?
Disclaimer: This information is sourced from Grants.gov and SAM.gov and is for informational purposes only. Opportunity details, deadlines, and eligibility requirements change frequently. Always verify current information directly on Grants.gov before applying. PlainGrants is not affiliated with any federal agency.
Read our methodology - how this data is sourced, computed, and verified.
Related
| Publisher | PlainGrants |
| Sources | the SAM.gov Assistance Listings and Grants.gov |